Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

27.82
Delayed Data
As of Oct 18
 -0.19 / -0.68%
Today’s Change
10.21
Today|||52-Week Range
31.84
+110.28%
Year-to-Date
No recent news for Insmed Inc.

Today’s Trading

Previous close28.01
Today’s open28.18
Day’s range27.36 - 28.29
Volume470,639
Average volume (3 months)1,157,745
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-41.09%
Earnings growth (this year)+5.84%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book11.25

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...-0.19-1.04%
AKAOAchaogen Inc-0.09-0.66%
SPPISpectrum Pharmaceuti...+5.21+36.03%
FLXNFlexion Therapeutics...-1.09-4.30%
Data as of 3:59pm ET, 10/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$0.00
Annual profit (last year)-$176.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Will Lewis
Chief Financial Officer
Paolo Tombesi
Corporate headquarters
Bridgewater, New Jersey

Forecasts